Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Jun 2026 for Biocryst Pharmaceuticals INC. Read the official filing
Filing timeline
BuySaleSteven K. Galson
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Steven K. Galson: trading record in brief
Steven K. Galson (board member) discloses dealings in Biocryst Pharmaceuticals Inc to SEC (Form 4). In total, 6 filings cover trades dated from 7 June 2022 to 11 June 2026.
On the market, this insider has only ever bought: 1 purchase, €112k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 5 share grants.
The latest filing, published on 15 June 2026, reports a share grant in Biocryst Pharmaceuticals Inc. The most recent open-market purchase was published on 15 May 2024, 886 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Steven K. Galson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
15,294 sharesCommon StockSEC:0000882796-26-000053:0
12,500 shares0Common StockSEC:0001171843-25-003912:0
6,820 shares0Common StockSEC:0001127602-24-018711:0
21,940 shares@ US$5.49100.0% of flowCommon StockSEC:0001127602-24-015369:0
Canonical exit: 11 Aug 2024 (T+90)
16,745 shares0Common StockSEC:0001127602-23-018788:0
12,866 shares0Common StockSEC:0001127602-22-017141:0
6 of 6 declarations
